BIOXCEL THERAPEUTICS INC

CUSIP: 09075P105 Class: Common Stock

RHUMBLINE ADVISERS's Holding History (CIK: 0001115418)

Note: Option positions (PUT/CALL) are excluded.

Q2 2024
Shares 11,502 Value ($000) $15 Avg Close — Range —
Q1 2024
Shares 29,685 Value ($000) $84 Avg Close — Range —
Q4 2023
Shares 28,984 Value ($000) $85 Avg Close — Range —
Q3 2023
Shares 27,393 Value ($000) $69 Avg Close — Range —
Q2 2023
Shares 28,257 Value ($000) $188 Avg Close — Range —
Q1 2023
Shares 33,490 Value ($000) $1 Avg Close — Range —
Q4 2022
Shares 30,854 Value ($000) $1 Avg Close — Range —
Q3 2022
Shares 30,353 Value ($000) $359 Avg Close — Range —
Q2 2022
Shares 28,511 Value ($000) $376 Avg Close — Range —
Q1 2022
Shares 18,206 Value ($000) $381 Avg Close — Range —
Q4 2021
Shares 16,102 Value ($000) $327 Avg Close — Range —
Q3 2021
Shares 15,312 Value ($000) $465 Avg Close — Range —
Q2 2021
Shares 14,498 Value ($000) $421 Avg Close — Range —
Q1 2021
Shares 13,575 Value ($000) $586 Avg Close — Range —
Q4 2020
Shares 15,230 Value ($000) $704 Avg Close — Range —
Q3 2020
Shares 13,818 Value ($000) $599 Avg Close — Range —
Q2 2020
Shares 15,463 Value ($000) $820 Avg Close — Range —